Propranolol may become first-line treatment in obstructive subglottic infantile hemangiomas

Otolaryngology - Head and Neck Surgery

Volumn 142, Issue 3, 2010, Pages 463-464

  Denoyelle, Françoise ^a   Garabédian, Erea Noël ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL; VINCRISTINE;

BLOOD GLUCOSE MONITORING; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR FUNCTION; COMPARATIVE STUDY; DRUG DOSE INCREASE; ENDOTRACHEAL TUBE; GRANULOMA; HUMAN; HYPOGLYCEMIA; HYPOTENSION; LASER SURGERY; LETTER; OBSTRUCTIVE SUBGLOTTIC INFANTILE HEMANGIOMA; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; RISK BENEFIT ANALYSIS; STEROID THERAPY; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR TUMOR; WEANING;

ADRENERGIC BETA-ANTAGONISTS; HEMANGIOMA; HUMANS; LARYNGEAL NEOPLASMS; PROPRANOLOL;

EID: 77049101246     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2009.10.044     Document Type: Letter

References (3)

1. Léauté-Labrèze C., Dumas de la Roque E., Hubiche T., et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 358 (2008) 2649-2651
2. Denoyelle F., Leboulanger N., Enjolras O., et al. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 73 (2009) 1168-1172
3. Siegfried E.C., Keenan W.J., and Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 359 (2008) 2846